Cloud Banner

Medical Devices

Image

Global Acute Ischemic Stroke Diagnosis and Treatment Market – Industry Trends and Forecast to 2030

  • Medical Devices
  • Upcoming Report
  • Jun 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Acute Ischemic Stroke Diagnosis and Treatment Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 6.7% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 1479.77 Million
Diagram Market Size (Forecast Year) USD 2558.32 Million
Diagram CAGR 6.7%

Global Acute Ischemic Stroke Diagnosis and Treatment Market, By Type (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography, Others), Surgery Type (Carotid Endarterectomy, Angioplasty, Endovascular Mechanical Thrombectomy), Treatment (Tissue Plasminogen Activator, Anticoagulant, Antiplatelet, Antihypertensive), Age Group (Adult, Geriatric, Child) – Industry Trends and Forecast to 2030.

Acute Ischemic Stroke Diagnosis and Treatment Market

Acute Ischemic Stroke Diagnosis And Treatment Market Analysis and Size   

Acute ischemic stroke generally refers to a sudden loss of certain brain functions due to uneven or lack of blood to the brain. Acute ischemic functions are largely produced by atherosclerosis plaques blocking blood vessels, blood clots locking the blood distribution to or from arteries nourishing the brain, or narrowing of blood vessels of the brain. The rapid technological advancement in diagnosis and surgical equipment is among the significant factors expected to fuel the growth and demand of the acute ischemic stroke diagnosis and treatment market. In addition, the increase in the number of patients with stroke and the rise in ischemic stroke cases are also anticipated to push the growth in the global acute ischemic stroke diagnosis and treatment market over the forecast period of 2023 to 2030.

Data Bridge Market Research analyses that the acute ischemic stroke diagnosis and treatment market, which was USD 1479.77 million in 2022, would rocket up to USD 2558.32 by 2030 and is expected to undergo a CAGR of 6.7% during the forecast period. “Magnetic Resonance Imaging (MRI)” dominates the type segment of the acute ischemic stroke diagnosis and treatment market owing to the preciseness in diagnosing ischemic stroke. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Acute Ischemic Stroke Diagnosis And Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Type (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography, Others), Surgery Type (Carotid Endarterectomy, Angioplasty, Endovascular Mechanical Thrombectomy), Application (Tissue Plasminogen Activator, Anticoagulant, Antiplatelet, Antihypertensive)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Abbott (U.S.), Cardinal Health (U.S), Genentech, Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GENERAL ELECTRIC (U.S.), Stryker (U.S.), Merck & Co., Inc. (U.S.), Siemens Healthcare Private Limited (Germany), Hitachi Medical Systems (Japan), Boston Scientific Corporation (U.S.), Neusoft Corporation (China), CANON MEDICAL SYSTEMS CORPORATION (Japan), Teleflex Incorporated (U.S.), Bayer AG (Germany), B. Braun Melsungen AG (Germany), AliveCor, Inc. (U.S.), F. Sanofi (France), and Johnson & Johnson Services, Inc. (U.S.)

Market Opportunities

  • Increasing awareness regarding the stroke
  • Increasing favorable government initiatives

Market Definition

Acute ischemic stroke is when blood flow to the brain is suddenly blocked, leading to brain cell damage. Diagnosis involves assessing medical history, physical examination, and neuroimaging techniques such as CT or MRI scans. Treatment aims to restore blood flow and prevent further damage. Options include administering clot-dissolving drugs or performing a mechanical thrombectomy to remove the clot directly.

Acute Ischemic Stroke Diagnosis And Treatment Market Dynamics

Drivers

  • Increasing Prevalence of Stroke

The rising prevalence of stroke cases worldwide is a major driver of the acute ischemic stroke market. Factors such as an aging population, sedentary lifestyles, high blood pressure, diabetes, and obesity increase the incidence of stroke, leading to a higher demand for diagnosis and treatment options.

  • Technological Advancements in Diagnostics and Imaging

Advances in diagnostic techniques and neuroimaging technologies have greatly improved the ability to detect and diagnose acute ischemic stroke. Innovations in CT scans, MRI scans, and other imaging modalities enable quicker and more accurate identification of ischemic stroke, leading to timely intervention and treatment.

Opportunities

  • Increasing awareness regarding the stroke

The increase in awareness regarding the stroke and its available treatment options in the market, favorable government initiatives and rapid rise in technological advancements in surgical procedures are expected to offer significant growth opportunities for the acute ischemic stroke diagnosis and treatment market in the forecast period of 2023-2030.

Restraints/Challenges

  • High cost of treatment

The high cost of treatment and unfavorable reimbursement scenario are estimated to limit the growth of the acute ischemic stroke diagnosis and treatment market, whereas the various complexities related to product development and manufacturing can challenge the growth of the acute ischemic stroke diagnosis and treatment market in the forecast period of 2023-2030

This acute ischemic stroke diagnosis and treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Ischemic  stroke diagnosis and treatment Market contact Data Bridge Market Research for an Analyst Brief. Our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In April 2023, Genentech announced partnership with University of Washington, Institute for Health Metrics and Evaluation (IHME), PicnicHealth and Cleveland Clinic to focus on improving brain health outcomes. This collaboration majorly focuses on assessing the complexity, and economic impact on patients during neurological care

  • In October 2022, Royal Philips announced that it will showcase its latest advances to support the treatment of stroke patients. Also, the company is working in association with stroke care partners such as MedTech stroke care company Nicolab to enable quick and effective response for stroke patients.

Global Acute Ischemic Stroke Diagnosis and Treatment Market Scope

The acute ischemic stroke diagnosis and treatment market is segmented based on type, surgery type, treatment, and age group. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.

Type

  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Carotid Ultrasound
  • Cerebral Angiography
  • Electrocardiography
  • Echocardiography
  • Others

Surgery Type

  • Carotid Endarterectomy
  • Angioplasty
  • Endovascular Mechanical Thrombectomy

Treatment

Age Group

  • Adult
  • Geriatric
  • Child

Acute Ischemic Stroke Diagnosis and Treatment Market Regional Analysis/Insights

The acute ischemic stroke diagnosis and treatment market is analysed and market size insights and trends are provided by country, type surgery type, treatment, age group, as referenced above.

The countries covered in the acute ischemic stroke diagnosis and treatment market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America.

North America dominates the market because its well-advanced healthcare system supports strong research and development activities for ischemic stroke diagnosis and treatment research. Many major players in the market have a stronghold in North America, contributing to the distribution of ischemic stroke diagnosis and treatment for all other regions worldwide.

Asia-Pacific is expected to grow the market in the forecast period of 2023-2030 because of the rising population at risk of ischemic stroke.

The country section of the report also provides individual market-impacting factors and domestic regulation changes that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The acute schemic stroke diagnosis and treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for acute ischemic stroke diagnosis and treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the acute ischemic stroke diagnosis and treatment market. The data is available for historic period 2010-2020.

Competitive Landscape and Acute Ischemic  Stroke Diagnosis And Treatment Market Share Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the acute ischemic stroke diagnosis and treatment market are:

  • Abbott (U.S.)
  • Cardinal Health (U.S)
  • Genentech, Inc. (U.S.)
  • Koninklijke Philips N.V. (Netherlands)
  • Medtronic (Ireland)
  • GENERAL ELECTRIC (U.S.)
  • Stryker (U.S.)
  • Merck & Co., Inc. (U.S.)
  • Siemens Healthcare Private Limited (Germany)
  • Hitachi Medical Systems (Japan)
  • Boston Scientific Corporation (U.S.)
  • Neusoft Corporation (China)
  • CANON MEDICAL SYSTEMS CORPORATION (Japan)
  • Teleflex Incorporated (U.S.)
  • Bayer AG (Germany)
  • B. Braun Melsungen AG (Germany)
  • AliveCor, Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd (Siwtzerland)
  • Sanofi (France)
  • Johnson & Johnson Services, Inc. (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Acute Ischemic Stroke Diagnosis and Treatment Market is known to be worth USD 2558.32 by 2030.
The Growth Rate of Acute Ischemic Stroke Diagnosis and Treatment Market is 6.7 % by 2030.
The rising prevalence of stroke cases worldwide is a growth driver of the acute ischemic stroke market.
The major companies in the acute ischemic stroke diagnosis and treatment market are Abbott, Cardinal Health, Genentech, Inc., Koninklijke Philips N.V. , Medtronic, GENERAL ELECTRIC , etc.
The type, surgery type, treatment, and age group are the factors on which the Acute Ischemic Stroke Diagnosis and Treatment Market research is based.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials